Ergots 发表于 2025-3-23 11:35:31
978-3-642-73723-7Springer-Verlag Berlin Heidelberg 1989BINGE 发表于 2025-3-23 15:59:25
https://doi.org/10.1007/978-3-030-62171-1l targets for the diagnosis and therapy of cancer. Research efforts in this area have intensified during the last decade because of the availability of monoclonal antibodies and the rapid emergence of increasingly sophisticated technologies of gene cloning. The relatively slow progress in the clinicaltruism 发表于 2025-3-23 18:48:30
http://reply.papertrans.cn/23/2213/221213/221213_13.pngBULLY 发表于 2025-3-24 01:49:22
https://doi.org/10.1007/978-3-663-10899-3. Monoclonal antibody technology enables an antibody-producing lymphocyte to be fused with a cultured myeloma cell, thus producing a hybridoma that secretes a specific monoclonal antibody. It is now possible to manufacture large quantities of immunoglobulins with unique specificity. Monoclona一再遛 发表于 2025-3-24 04:40:03
http://reply.papertrans.cn/23/2213/221213/221213_15.pngforestry 发表于 2025-3-24 07:50:59
http://reply.papertrans.cn/23/2213/221213/221213_16.pngdagger 发表于 2025-3-24 11:48:01
https://doi.org/10.1007/978-3-031-21622-0ially on fetal cells. On normal mature cells, TAA might be detected only by highly sensitive techniques or after manipulation of the cell membrane. On malignant cells, TAA are often re-expressed in high concentrations. Such antigens can be exploited not only for diagnostic purposes, but also as targNuance 发表于 2025-3-24 18:35:40
http://reply.papertrans.cn/23/2213/221213/221213_18.png丰满中国 发表于 2025-3-24 19:41:07
http://reply.papertrans.cn/23/2213/221213/221213_19.pngPANIC 发表于 2025-3-25 02:06:56
Introductory Remarks at the Overview Session. The molecular basis of the differential sensitivity of cancer tissues for these drugs as compared with normal tissues remains, however, largely undefined. It has been postulated that differences in the kinetics of cell proliferation are the basis of this differential sensitivity. This has been dem